We tried to select and validate the candidate gene for the prognostic marker of breast cancer by comparing the analysis of copy number variation (CNV) between normal breast tissues and breast cancer tissues by performing array comparative genomic hybridization (CGH). Methods: Array CGH was performed with using the fresh frozen tissues of 77 breast cancer patients. We selected the clones with more than a 20% frequency of gain or loss, and the clones with gain or loss in more than 2 consecutive clones. We finally selected the clones that were statistically significant on the survival analysis. We searched for the candidate gene that belonged to the candidate clones and we selected the final candidate gene that is assumed to be most related to the carcinogenesis of breast cancer by searching for information of the individual gene. We performed RT-PCR to validate the RNA expression of the final candidate gene with using the breast tissues of another 20 breast cancer patients. Results:
Log2 값을뺀값으로정의하였다(Log2 ratio=Log2Cy3-Log2Cy5). Recurrece interval (months)
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Systemic recurrence-free survival c2806 gain (-) Figure 1 . Survival curve of systemic recurrence-free survival analysis for the clone which contains COL18A1 gene (c2806) by Kaplan-Meier test. The survival of the group with gain of c2806 clone was better than that without gain of c2806 clone and the difference of survival between two groups was statistically significant (p= 0.008) by log rank test. 참고문헌
